The NGS of all the MCAD cases had no MYC mutation, but only in MCAD was TP53 mutated, suggesting that MCAD is genetically different from DHL/THL and SHL. This evidence concerns the gene TP53 and medium chain acyl-CoA dehydrogenase deficiency.